Rho D Activators
Rho D Activators are compounds that influence cellular signaling pathways and molecular processes to modulate the activity of Rho D, a member of the Rho family of GTPases involved in the organization of the actin cytoskeleton and regulation of cell motility. These activators do not directly bind and activate Rho D but affect various regulators and processes that can lead to its activation. The mechanism of activation can involve the inhibition of related Rho GTPases or their downstream effectors, leading to compensatory upregulation of Rho D's activity, or can be the result of alterations in post-translational modifications that affect Rho D's localization and function.
Some activators work by inhibiting enzymes like calpain, which might otherwise lead to the inactivation of Rho D, or by inhibiting the activity of related GTPases like Cdc42 and Rac1, prompting the cell to adjust by activating Rho D. Others, like LPA, work through GPCRs to promote the activation of Rho GTPases. Additionally, some activators, such as FTIs and GGTIs, disrupt the normal regulation of Rho GTPases by inhibiting the addition of lipid modifications required for their proper localization and function, which can indirectly increase the activity of Rho D.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpeptin is a calpain inhibitor. Calpain can regulate GTPase activity, and its inhibition may result in the activation of Rho D by preventing its inactivation. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a Cdc42 GTPase inhibitor. By inhibiting Cdc42, there may be a compensatory activation of Rho D as a part of the cellular homeostasis of Rho GTPase activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor. Rho-associated kinase (ROCK) is downstream of Rho GTPases, and its inhibition can lead to feedback loops that activate Rho proteins, including Rho D. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Statin inhibits HMG-CoA reductase. This drug leads to the depletion of isoprenoids that are necessary for the post-translational modification and membrane association of Rho GTPases, potentially affecting Rho D activity. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA is a bioactive lipid that activates Rho GTPases through G protein-coupled receptors (GPCRs), which may enhance Rho D activation as part of signal transduction. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
GTPγS is a non-hydrolyzable analog of GTP. It can bind and activate GTPases like Rho D, albeit non-specifically, by mimicking the active GTP-bound state. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin, similar to statins, decreases isoprenoid biosynthesis which can affect the post-translational modification of Rho GTPases and thereby influence Rho D activity. | ||||||